Andrew Nation,Ashvinikumar Gavai,Brian Fink,Libing Chen,Liqi He,Litai Zhang,Soong-Hoon Kim,YUFEN ZHAO
申请号:
BRPI0920135
公开号:
BRPI0920135A2
申请日:
2009.10.08
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.